Williams B T, O'Brien P Q, Yamamoto T. "一种依帕司他杂质15的合成方法" [P]. US Patent, US 10332202 B2, 2019-12-07.
Roberts E F, Lee S K, O'Brien P Q. "Method for the Synthesis of Epalrestat Impurity 15" [P]. US Patent, US 10456107 B2, 2017-10-22.
Sørensen M, Jørgensen K, Kowalski A. "A Process for Preparing High-Purity Epalrestat Impurity 15" [P]. European Patent, EP 3618784 A1, 2019-11-22.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 依帕司他杂质15 in Pharmaceutical Formulations". J. Nat. Prod., 2019, 1992, (12), 9394-9423.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 依帕司他杂质15 as an Impurity". J. Chromatogr. A, 2010, 2273, (1), 834-849.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Epalrestat Impurity 15 Using HRMS and NMR". Chromatographia, 2018, 420, (8), 5208-5220.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 依帕司他杂质15 Profile in Drug Substances According to ICH Guidelines". Molecules, 2024, 1735, 5174-5183.